RVMD
Revolution Medicines Inc
190.70$
-1.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +26.8% | -13.6% | -89.2% | +1,087.9% | +23.9% | +9.4% | -98.2% | – | – | -3.6% | – | – | |
| – | – | -16,005.8% | – | – | – | – | – | – | – | – | – | – | |
| – | +37.8% | -20.5% | +14.3% | +12.5% | +23.9% | +9.4% | +8.9% | +17.1% | +11.5% | +17.6% | +14.8% | – | |
| – | +107.9% | -29.2% | -4.9% | +10.4% | +17.8% | +24.1% | +15.9% | +30.0% | +21.9% | +57.4% | +8.9% | – | |
| – | +46.6% | -22.1% | +11.2% | +12.2% | +23.1% | +11.3% | +9.9% | +19.1% | +13.2% | +23.5% | +14.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +1,171.2% | +4.4% | +2.2% | +95.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -905.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.